A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1998
10/01/1998	WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998	WO1998042737A2 Peptides for the treatment of systemic lupus erythematosus
10/01/1998	WO1998042729A2 Steroid sulfamates, method for the production and use thereof
10/01/1998	WO1998042713A1 2,3-DIHYDROFURO[3,2-b]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY
10/01/1998	WO1998042706A1 Method of making arylamino triazolopyridines
10/01/1998	WO1998042696A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
10/01/1998	WO1998042687A1 Lipase catalyzed dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids
10/01/1998	WO1998042686A1 Ldl receptor gene expression promoters
10/01/1998	WO1998042673A1 Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist
10/01/1998	WO1998042670A1 Novel pyridine derivatives and pharmaceutical compositions containing them
10/01/1998	WO1998042659A2 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals
10/01/1998	WO1998042378A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
10/01/1998	WO1998042376A1 Composition comprising immunoglobulin
10/01/1998	WO1998042366A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
10/01/1998	WO1998042365A1 Ligand/lytic peptide compositions and methods of use
10/01/1998	WO1998042364A1 Ligand/lytic peptide compositions and methods of use
10/01/1998	WO1998042358A1 Methods for treating vascular disorders
10/01/1998	WO1998042357A1 Use of an extract of alchemilli vulgaris
10/01/1998	WO1998042353A1 Modulation of human mast cell activation
10/01/1998	WO1998042344A1 Pharmaceutical composition
10/01/1998	WO1998042342A1 Thrombin inhibitors
10/01/1998	WO1998042339A1 Use of chelerythrine and radiation for tumor therapy
10/01/1998	WO1998042338A1 Extension of the expression of transgenic proteins by immunomodulation
10/01/1998	WO1998042328A1 Di-aryl ethers and their derivatives as anti-cancer agents
10/01/1998	WO1998042327A2 Vascular remodeling agent
10/01/1998	WO1998042296A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998	WO1998025593A3 2-cyclopenten-1-one and its derivatives as inhibitors of the nf-kb factor
10/01/1998	WO1998022580A3 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
10/01/1998	DE19712488A1 Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben Steroidsulfamate, processes for their preparation and use thereof
10/01/1998	CA2285530A1 Di-aryl ethers and their derivatives as anti-cancer agents
10/01/1998	CA2285439A1 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals
10/01/1998	CA2284992A1 Use of chelerythrine and radiation for tumor therapy
10/01/1998	CA2284719A1 Nasal melatonin composition
10/01/1998	CA2284710A1 Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist
10/01/1998	CA2284548A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
10/01/1998	CA2284279A1 Methods for treating vascular disorders
10/01/1998	CA2284261A1 Methods to identify .beta.-amyloid reducing agents
10/01/1998	CA2284200A1 Novel pyridine derivatives and pharmaceutical compositions containing them
10/01/1998	CA2284095A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998	CA2283965A1 Composition comprising immunoglobulin
10/01/1998	CA2283932A1 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998	CA2283792A1 Peptides for the treatment of systemic lupus erythematosus
10/01/1998	CA2283704A1 Thrombin inhibitors
10/01/1998	CA2283631A1 Secreted proteins and polynucleotides encoding them
10/01/1998	CA2283234A1 Lipase catalyzed dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids
10/01/1998	CA2283230A1 Method of making arylamino triazolopyridines
10/01/1998	CA2282320A1 2,3-dihydrofuro¬3,2-b\|pyridin, preparation and application thereof in therapy
09/1998
09/30/1998	EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10
09/30/1998	EP0867508A2 Olfactory receptor of the 7-transmembrane receptor family - OLRCC15 receptor
09/30/1998	EP0867447A1 Water-soluble extract of asiaticoside and madecassoside from centella asiatica and isolating method thereof
09/30/1998	EP0867438A1 Rapamycin derivatives and their use, particularly as immunosuppressants
09/30/1998	EP0867432A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists
09/30/1998	EP0867192A2 Combinatory compositions for the treatment of dementia containing at least a compound having acetylcholinesterase-inhibitory or muscarinic activity and a compound that enhances the endogenous extracellular adenosine levels
09/30/1998	EP0867184A1 Use of tiagabine for the treatment of sleep disorders
09/30/1998	EP0867182A2 The use of certain NK-1 receptor antagonists for the manufacture of a medicament for treating emesis
09/30/1998	EP0867178A1 Non-allosteric GABA A agonists for treating sleep disorders
09/30/1998	EP0866857A1 E6 binding proteins
09/30/1998	EP0866852A1 Tissue-specific and target rna-specific ribozymes
09/30/1998	EP0866790A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists
09/30/1998	EP0866722A1 Improved formulation for administration of steroid compounds
09/30/1998	EP0866718A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells
09/30/1998	EP0866711A1 Method of inhibiting sleep apnea
09/30/1998	EP0866706A1 Treatment of traumatic brain injury
09/30/1998	EP0866699A1 The use of cholinesterase inhibitors in the treatment of xerostomia
09/30/1998	EP0866691A1 Sublingual and buccal administration of selegiline
09/30/1998	EP0866656A1 Inhibition of tumor necrosis factor alpha
09/30/1998	EP0831726A4 Health food product
09/30/1998	EP0542807B1 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one
09/30/1998	EP0526544B1 Therapeutic uses of actin-binding compounds
09/30/1998	CN1194647A Pyrrolopyrimidines and processes for preparation thereof
09/30/1998	CN1194583A Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignancies
09/30/1998	CN1194159A Specific quick catalytic injection
09/30/1998	CN1040003C Process for preparing trifluoromethylktone derivatives
09/30/1998	CN1039998C Substituted cycloalkylacetamides and its preparation, medicine and use
09/30/1998	CN1039996C N-substituted azabicycloheptane devivatives and its use
09/29/1998	US5814661 Treatment of shock and reducing tumor necrosis factor
09/29/1998	US5814648 N-hydroxyureas as antiinflammatory agents
09/29/1998	US5814647 Use of troglitazone and related compounds for the treatment of the climacteric symptoms
09/29/1998	US5814643 Sulfonamide fibrinogen receptor antagonists
09/29/1998	US5814630 Quinazoline compounds
09/29/1998	US5814622 Compound useful as trypsin like serine protease as thrombin inhibitors
09/29/1998	US5814610 Tetrapeptides to hexapeptides with specific amino acid sequences for wound healing agents and osteoblast or fibroblastic growth promoters
09/29/1998	US5814607 Pulmonary delivery of active fragments of parathyroid hormone
09/29/1998	US5814604 A pair of polypeptide chains disulfide bonded to form a dimeric species
09/29/1998	US5814603 Parathyroid hormone peptide with amino acid sequences
09/29/1998	US5814512 Microorganism having all the identifying characteristics of absida ferm BP-4599 for producing purpurogallin derivatives
09/29/1998	US5814339 Core of a mixture of the drugs and a carrier of below 20% total weight; migraine headaches
09/29/1998	US5814308 Administering macrophage stimulating protein to treat disorders caused by radiation chemotherapy, ulcers or autoimmune diseases, for regeneration of intestinal crypt cells
09/29/1998	CA2100503C Piperidine derivatives of benzimidazole
09/28/1998	CA2233377A1 Nk-1 receptor antagonists for the treatment of delayed emesis
09/27/1998	CA2232499A1 Benzyloxy-substituted, fused n heterocycles, process for their preparation, and their use as bradykinin reception antagonists
09/27/1998	CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10
09/24/1998	WO1998041628A1 Secreted salivary zsig32 polypeptides
09/24/1998	WO1998041539A2 Secreted proteins and polynucleotides encoding them
09/24/1998	WO1998041538A2 Novel human cytokine/steroid receptor protein
09/24/1998	WO1998041528A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
09/24/1998	WO1998041527A1 Pyrroloazepine compounds
09/24/1998	WO1998041525A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors
09/24/1998	WO1998041519A1 Novel cannabinoid receptor agonists
09/24/1998	WO1998041516A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors

1 ... 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 ... 1564